November 2010

Leadership Forum: Looking into the 2011 Crystal Ball ()
Ambulatory EMR: Its No Longer Just About Inpatient Data ()
CCTA Gains Ground for Low-Risk Chest Pain ()
Clarian Sees Success with Level I Vascular Emergency Program ()
First Word: Looking Forward to 2011 ()
The Back Page: Growing Patient Advocacy Will Impact Practice ()
AHA: Protocol reduces children's rad exposure during EP procedures ()
AHA: Cardiac MR helps outline risks for left ventricular non-compaction ()
Medtronic books dip in earnings, despite CV sales increase in Q2 ()
New guidelines outline performance measures for PAD ()
Circ: Congenital heart disease deaths drop, but not for all ()
VEITH: Endurant Endograft stent shows promise for AAAs ()
Zoll books solid gains for Q4, FY10 ()
AHA: CRP screening may not improve CV risk assessments, ASCOT shows ()
Apixaban trial for ACS patients stopped ()
Circ: Post-discharge mortality has increased for older AMI patients ()
As they roll their rock of Sisyphus ()
AHA: ACT now! Stop using NAC to protect kidneys from contrast ()
FDA seeks to improve manufacturing of AEDs ()
Thomson Reuters' Top 50 cardiac hospitals deliver safe, cost-effective care ()
Clinical communication ringing loud and clear ()
Former AHA Prez Gibbons: GRAVITAS will not lead to increased platelet testing ()
AHA: DES = BMS for large coronary arteries, but not conclusively ()
AHA: Non-adherence to statins after MI decreases ACS-free survival ()
AHA: Gene therapy for CLI fails to live up to initial hypenext stop, stem cells? ()
CCI: Open SESAME: Stent shows multiple successes in SVG lesions ()
AHA: Pre-hospital ECGs are cost effective for STEMI patients ()
AHA Video: Price unveils GRAVITAS results ()
AHA: Potential benefits of using rivaroxaban for AF stroke prevention still unclear ()
Utah hits GSK with $7.8M suit alleging improper Avandia marketing ()
AHA: Off-label PFO closure for stroke, TIA prevention needs to stop ()
AHA: CAD treatment for uninsured is subpar, but better for HF ()
AHA: In-hospital use of AEDs needs rethinking ()
AHA Video: Ticagrelor may negate the need to assess genetic variations ()
AHA Video: SMART AV does not reveal clear path to assisting CRT non-responders ()
AHA Video: Cohen reviews quality-of-life data of PARTNER, touches upon costs ()
AHA: Eplerenone shows promise for mild HF--questions arise on real-life use ()
AHA: Good news, bad news for nesiritide--docs must decide for themselves ()
AHA: RAFT suggests widening ICD-CRT indications for lesser HF ()
AHA: Hospital certification program for cardiovascular, stroke care needed ()
AHA: Antman wins councils highest honor ()
AHA: Therapeutic hypothermia decisions might be too subjective ()
AHA: Wait, possibly, before stopping hypothermia for arrest patients ()
Feature: AEDs save lives if bystanders know how to use them ()
Panasonic unveils tool to detect at-risk cardiac patients ()
AHA: More testing does not facilitate better heart disease diagnosis ()
AACR Feature: Genetic test may help target lung cancer CT screening ()
Do ACOs provide more questions than answers? ()
Physio-Control/AirStrip partner to advance pre-hospital care ()
HRJ: Hybrid surgical approach allows EPs to ablate heart's surface ()
Feature: Cardiologists should team with PCPs for best HF patient outcomes ()
Two cardiac innovations make Cleveland Clinic's Top 10 for 2011 ()
Maryland provider to pay $22M to settle kickback, stenting issues ()
Global Impella sales improve Abiomeds Q2 results ()
HRJ: Internal med docs are uncomfortable deactivating ICDs ()
JACC: Transradial approach gains traction, but practice variances abound ()
JACC: Long-term surgical risks surface after pediatric valvuloplasty ()
Toshiba unveils 32 element coils ()
Circ: COURAGE reveals PCI, medical therapy don't vary among healthcare systems ()
Report: Global CV surgery device market to reach $2.4B by 2016 ()
Thoratec narrows focus on LVADs through $55M sale of ITC ()
ACC/AHA: New quality measures for cardiac care detail construction, collection ()
AJC: ACS patients better off in RCTs than registries ()
Lancet: Dabigatran similar to warfarin for those with prior stroke/ischemic attack ()
JACC: Multi-society doc attempts to clarify PPI, antiplatelet combo ()
El Camino's new vascular program combines endo, surgical ()
Lancet: Paricalcitol + RAAS inhibitors VITAL for curbing renal risk ()
Watchman hopes to PREVAIL through U.S. AF trial ()
NHLB awards U of Illinois $12M for HF research ()
Drug-coated balloons find niche where DES dare not go ()
CSI to settle ev3 suit for $1M ()
Endoscopy: First video capsule endoscopy in stomach ()
JACC: Gait speed predicts outcomes in elderly CABG patients ()
Circ: TAVI trumps SAVR in stenotic patients with decreased LVEF ()
HRS, FDA express views over proposed midodrine withdrawal ()
Pfizer recalls 38K bottles of Lipitor ()
AIM: Model shows scenarios for dabigatran's cost effectiveness ()
Platelet Function Testing: Time to Get Personal ()
First Word: Personalized Care Extends Outward ()
Compression-Only CPR Gets More than Lip Service ()
PET Helps Cushion Nuclear Reimbursement Cuts ()
Patient Monitoring Moves Beyond Hospital Walls ()
The ACC Corner: Linking Providers with Payors Helps Navigate Healthcare Reform ()
Medicines Co. skips into the black for Q3, partly due to Angiomax sales ()
B.Braun recalls seven lots of heparin sodium ()